Cargando…

Nanocarriers for Skin Applications: Where Do We Stand?

Skin penetration of active molecules for treatment of diverse diseases is a major field of research owing to the advantages associated with the skin like easy accessibility, reduced systemic‐derived side effects, and increased therapeutic efficacy. Despite these advantages, dermal drug delivery is g...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Neha, Osorio‐Blanco, Ernesto Rafael, Sonzogni, Ana, Esporrín‐Ubieto, David, Wang, Huiyi, Calderón, Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292798/
https://www.ncbi.nlm.nih.gov/pubmed/34487599
http://dx.doi.org/10.1002/anie.202107960
_version_ 1784749462904635392
author Tiwari, Neha
Osorio‐Blanco, Ernesto Rafael
Sonzogni, Ana
Esporrín‐Ubieto, David
Wang, Huiyi
Calderón, Marcelo
author_facet Tiwari, Neha
Osorio‐Blanco, Ernesto Rafael
Sonzogni, Ana
Esporrín‐Ubieto, David
Wang, Huiyi
Calderón, Marcelo
author_sort Tiwari, Neha
collection PubMed
description Skin penetration of active molecules for treatment of diverse diseases is a major field of research owing to the advantages associated with the skin like easy accessibility, reduced systemic‐derived side effects, and increased therapeutic efficacy. Despite these advantages, dermal drug delivery is generally challenging due to the low skin permeability of therapeutics. Although various methods have been developed to improve skin penetration and permeation of therapeutics, they are usually aggressive and could lead to irreversible damage to the stratum corneum. Nanosized carrier systems represent an alternative approach for current technologies, with minimal damage to the natural barrier function of skin. In this Review, the use of nanoparticles to deliver drug molecules, genetic material, and vaccines into the skin is discussed. In addition, nanotoxicology studies and the recent clinical development of nanoparticles are highlighted to shed light on their potential to undergo market translation.
format Online
Article
Text
id pubmed-9292798
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92927982022-07-20 Nanocarriers for Skin Applications: Where Do We Stand? Tiwari, Neha Osorio‐Blanco, Ernesto Rafael Sonzogni, Ana Esporrín‐Ubieto, David Wang, Huiyi Calderón, Marcelo Angew Chem Int Ed Engl Reviews Skin penetration of active molecules for treatment of diverse diseases is a major field of research owing to the advantages associated with the skin like easy accessibility, reduced systemic‐derived side effects, and increased therapeutic efficacy. Despite these advantages, dermal drug delivery is generally challenging due to the low skin permeability of therapeutics. Although various methods have been developed to improve skin penetration and permeation of therapeutics, they are usually aggressive and could lead to irreversible damage to the stratum corneum. Nanosized carrier systems represent an alternative approach for current technologies, with minimal damage to the natural barrier function of skin. In this Review, the use of nanoparticles to deliver drug molecules, genetic material, and vaccines into the skin is discussed. In addition, nanotoxicology studies and the recent clinical development of nanoparticles are highlighted to shed light on their potential to undergo market translation. John Wiley and Sons Inc. 2021-10-01 2022-01-17 /pmc/articles/PMC9292798/ /pubmed/34487599 http://dx.doi.org/10.1002/anie.202107960 Text en © 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Reviews
Tiwari, Neha
Osorio‐Blanco, Ernesto Rafael
Sonzogni, Ana
Esporrín‐Ubieto, David
Wang, Huiyi
Calderón, Marcelo
Nanocarriers for Skin Applications: Where Do We Stand?
title Nanocarriers for Skin Applications: Where Do We Stand?
title_full Nanocarriers for Skin Applications: Where Do We Stand?
title_fullStr Nanocarriers for Skin Applications: Where Do We Stand?
title_full_unstemmed Nanocarriers for Skin Applications: Where Do We Stand?
title_short Nanocarriers for Skin Applications: Where Do We Stand?
title_sort nanocarriers for skin applications: where do we stand?
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292798/
https://www.ncbi.nlm.nih.gov/pubmed/34487599
http://dx.doi.org/10.1002/anie.202107960
work_keys_str_mv AT tiwarineha nanocarriersforskinapplicationswheredowestand
AT osorioblancoernestorafael nanocarriersforskinapplicationswheredowestand
AT sonzogniana nanocarriersforskinapplicationswheredowestand
AT esporrinubietodavid nanocarriersforskinapplicationswheredowestand
AT wanghuiyi nanocarriersforskinapplicationswheredowestand
AT calderonmarcelo nanocarriersforskinapplicationswheredowestand